Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 497429, 7 pages
http://dx.doi.org/10.1155/2010/497429
Review Article

Treatment for Recurrent Ovarian Cancer—At First Relapse

Department of OBGYN, Kurume University School of Medicine, 67 Asahi machi, Kurume 830-0011, Japan

Received 7 July 2009; Revised 27 September 2009; Accepted 15 October 2009

Academic Editor: Dennis S. Chi

Copyright © 2010 Kimio Ushijima. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [46 citations]

The following is the list of published articles that have cited the current article.

  • Shinichi Togami, Tomoyasu Kato, Takateru Oi, Mitsuya Ishikawa, Takashi Onda, Shun-ichi Ikeda, and Takahiro Kasamatsu, “A rare case of recurrent ovarian cancer presenting as a round ligament metastasis,” World Journal Of Surgical Oncology, vol. 9, 2011. View at Publisher · View at Google Scholar
  • Peter G. Rose, Bradley J. Monk, Diane Provencher, Jean Hartney, Philippe Legenne, and Stephen Lane, “An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21 days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer,” Gynecologic Oncology, vol. 120, no. 1, pp. 38–42, 2011. View at Publisher · View at Google Scholar
  • Gina M Mantia-Smaldone, Robert P Edwards, and Anda M Vlad, “Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.,” Cancer management and research, vol. 3, pp. 25–38, 2011. View at Publisher · View at Google Scholar
  • Joaquín Montalar, Gerardo Cajaraville, Maria-Josep Carreras, María Jesús Rubio, Beatriz García-San Andrés, Itziar Oyagüez, and Miguel Angel Casado, “Trabectedin plus PLD versus PLD monotherapy in patients with platinum-sensitive relapsed ovarian cancer: A cost-effectiveness analysis in Spain,” European Journal of Hospital Pharmacy: Science and Practice, vol. 19, no. 4, pp. 364–369, 2012. View at Publisher · View at Google Scholar
  • Remi Longuespee, Charlotte Boyon, Celine Castellier, Amelie Jacquet, Annie Desmons, Olivier Kerdraon, Denis Vinatier, Isabelle Fournier, Robert Day, and Michel Salzet, “The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling,” Histochemistry And Cell Biology, vol. 138, no. 1, pp. 141–154, 2012. View at Publisher · View at Google Scholar
  • Keith C. Bible, Prema P. Peethambaram, Ann L. Oberg, William Maples, David L. Groteluschen, Matthew Boente, Jill K. Burton, Leigh C. Gomez Dahl, Jennifer D. Tibodeau, Crescent R. Isham, Jacie L. Maguire, Viji Shridhar, Andrea K. Kukla, Kalli J. Voll, Mathew J. Mauer, Alexander D. Colevas, John Wright, L. Austin Doyle, and Charles Erlichman, “A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261,” Gynecologic Oncology, vol. 127, no. 1, pp. 55–62, 2012. View at Publisher · View at Google Scholar
  • August Vidal, Clara Munoz, Maria-Jose Guillen, Jemina Moreto, Sara Puertas, Maria Martinez-Iniesta, Agnes Figueras, Laura Padulles, Francisco J. Garcia-Rodriguez, Mireia Berdiel-Acer, Miguel A. Pujana, Ramon Salazar, Marta Gil-Martin, Lola Marti, Jordi Ponce, David G. Mollevi, Gabriel Capella, Enric Condom, Francesc Vinals, Dori Huertas, Carmen Cuevas, Manel Esteller, Pablo Aviles, and Alberto Villanueva, “Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer,” Clinical Cancer Research, vol. 18, no. 19, pp. 5399–5411, 2012. View at Publisher · View at Google Scholar
  • S. McMeekin, R. Patel, C. Verschraegen, P. Celano, J. Burke, S. Plaxe, P. Ghatage, M. Giurescu, C. Stredder, Y. Wang, and T. Schmelter, “Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer,” British Journal Of Cancer, vol. 106, no. 1, pp. 70–76, 2012. View at Publisher · View at Google Scholar
  • Vinicius Craveiro, Yang Yang-Hartwich, Jennie C. Holmberg, Natalia J. Sumi, John Pizzonia, Brian Griffin, Sabrina K. Gill, Dan-Arin Silasi, Masoud Azodi, Thomas Rutherford, Ayesha B. Alvero, and Gil Mor, “Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment,” Cancer Medicine, 2013. View at Publisher · View at Google Scholar
  • Kun Kim, Emma Hernlund, Zoltán Hernadi, János Révész, Imre Pete, András Szánthó, Lubomir Bodnar, Rodoslaw Madry, Agnieszka Timorek–Lemieszczuk, Tatjana Bozanovic, Suzana Vasovic, Zorica Tomasevic, Milica Zivaljevic, Vladimir Pazin, Tomáš Minárik, Hana Garanová, Lýdia Helpianska, and Nahila Justo, “Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review,” International Journal of Gynecological Cancer, vol. 23, no. 5, pp. 823–832, 2013. View at Publisher · View at Google Scholar
  • Itziar Oyagüez, Gerardo Cajaraville, José Campo, María-Josep Carreras, Joaquín Montalar, Jesús Rubio, Beatriz García-San Andrés, and Miguel Ángel Casado, “Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino,” PharmacoEconomics Spanish Research Articles, vol. 9, no. 3, pp. 83–94, 2013. View at Publisher · View at Google Scholar
  • Ramdane A. Harouaka, Merisa Nisic, and Si-Yang Zheng, “Circulating Tumor Cell Enrichment Based on Physical Properties,” Jala, vol. 18, no. 6, pp. 455–468, 2013. View at Publisher · View at Google Scholar
  • Madhuri Koti, Robert J. Gooding, Paulo Nuin, Alexandria Haslehurst, Colleen Crane, Johanne Weberpals, Timothy Childs, Peter Bryson, Moyez Dharsee, Kenneth Evans, Harriet E. Feilotter, Paul C. Park, and Jeremy A. Squire, “Identification of the IGF1/PI3K/NF kappa B/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer,” Bmc Cancer, vol. 13, 2013. View at Publisher · View at Google Scholar
  • B. W. C. Tse, A. Collins, M. K. Oehler, A. Zippelius, and V. A. Heinzelmann-Schwarz, “Antibody-based immunotherapy for ovarian cancer: where are we at?,” Annals of Oncology, 2013. View at Publisher · View at Google Scholar
  • Aibek E. Mirrakhimov, Alan D. Gilman, Nwabundo Nwankwo, Aram Barbaryan, Raya Saba, Alaa M. Ali, Shawn G. Kwatra, Nasir Hussain, Mourad H. Senussi, and Erwin Velasquez Kho, “Left inguinal adenopathy two years after cytoreductive surgery: A rare sign of recurrence,” Case Reports in Oncology, vol. 6, no. 1, pp. 31–35, 2013. View at Publisher · View at Google Scholar
  • Toru Tase, Hideki Mizunuma, Masayuki Futagami, Toshio Fujimoto, Nobuo Yaegashi, Yoshihito Yokoyama, Hiroshi Nishiyama, Eriko Takatori, Toru Sugiyama, Takeo Otsuki, Takanobu Kojimahara, Hirohisa Kurachi, Keiya Fujimori, and Yukihiro Terada, “Investigation of the clinicopathological features of fallopian tube malignancy,” Oncology Reports, vol. 30, no. 1, pp. 79–84, 2013. View at Publisher · View at Google Scholar
  • Supakorn Pitakkarnkul, Siriwan Tangjitgamol, Sunamchok Srijaipracharoen, Sumonmal Manusirivithaya, Kamol Pataradool, Watchara Prutthiphongsit, Jakkapan Khunnarong, and Thaovalai Thavaramara, “Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 4, pp. 2421–2427, 2013. View at Publisher · View at Google Scholar
  • Mariam Rodriguez-Lee, Peter Kuhn, and David R. Webb, “Advancing Cancer Patient Care by Integrating Circulating Tumor Cell Technology to Understand the Spatial and Temporal Dynamics of Cancer,” Drug Development Research, vol. 75, no. 6, pp. 384–392, 2014. View at Publisher · View at Google Scholar
  • Rekha Wuntakal, Srividya Seshadri, Ana Montes, and Geoff LaneCochrane Database of Systematic Reviews, 2014. View at Publisher · View at Google Scholar
  • Kevin H. Eng, “Randomized reverse marker strategy design for prospective biomarker validation,” Statistics in Medicine, 2014. View at Publisher · View at Google Scholar
  • Ramdane Harouaka, Zhigang Kang, Si-Yang Zheng, and Liang Cao, “Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.,” Pharmacology & therapeutics, vol. 141, no. 2, pp. 209–21, 2014. View at Publisher · View at Google Scholar
  • Kevin H. Eng, Bret M. Hanlon, William H. Bradley, and J. Brian Szender, “Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer,” Gynecologic Oncology, 2015. View at Publisher · View at Google Scholar
  • David Mizrahi, Carolyn Broderick, Michael Friedlander, Mary Ryan, Michelle Harrison, Kate Pumpa, and Fiona Naumann, “An exercise intervention during chemotherapy for women with recurrent ovarian cancer: A feasibility study,” International Journal of Gynecological Cancer, vol. 25, no. 6, pp. 985–992, 2015. View at Publisher · View at Google Scholar
  • Carrie D House, Lidia Hernandez, and Christina M Annunziata, “In vitro enrichment of ovarian cancer tumor-initiating cells,” Journal of Visualized Experiments, no. 96, 2015. View at Publisher · View at Google Scholar
  • Veethika Pandey, Jeremiah L. Oyer, Robert Y. Igarashi, Sarah B. Gitto, Alicja J. Copik, and Deborah A. Altomare, “Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells,” Oncotarget, vol. 7, no. 6, pp. 7318–7328, 2015. View at Publisher · View at Google Scholar
  • Alicia A. Tone, Marcus Q. Bernardini, K. Joan Murphy, Barry Rosen, Taymaa May, Jocelyn M. Stewart, Haiyan Jiang, Sarah Ferguson, and Stephane Laframboise, “The optimal time for surgery in women with serous ovarian cancer,” Canadian Journal of Surgery, vol. 59, no. 4, pp. 223–232, 2016. View at Publisher · View at Google Scholar
  • Rekha Wuntakal, Srividya Seshadri, Ana Montes, and Geoff LaneCochrane Database of Systematic Reviews, 2016. View at Publisher · View at Google Scholar
  • Matthew McKenzie, David Betts, Amy Suh, Kathryn Bui, Rui Tang, Kexian Liang, Samuel Achilefu, Glen S. Kwon, and Hyunah Cho, “Proof-of-Concept of Polymeric Sol-Gels in Multi-Drug Delivery and Intraoperative Image-Guided Surgery for Peritoneal Ovarian Cancer,” Pharmaceutical Research, 2016. View at Publisher · View at Google Scholar
  • Chunbai He, Christopher Poon, Christina Chan, S. Diane Yamada, and Wenbin Lin, “Nanoscale Coordination Polymers Co-deliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer,” Journal of the American Chemical Society, 2016. View at Publisher · View at Google Scholar
  • Peter Andorfer, Alexander Heuwieser, Andreas Heinzel, Arno Lukas, Bernd Mayer, and Paul Perco, “Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer,” BMC Systems Biology, vol. 10, no. 1, 2016. View at Publisher · View at Google Scholar
  • Xiao-Mei Fan, Jun Zhang, Shu-Huai Niu, Kui-Xiu Li, and Cang-Zhu Song, “Secondary cytoreductive surgery in recurrent epithelial ovarian cancer: A prognostic analysis with 103 cases,” International Journal of Surgery, 2016. View at Publisher · View at Google Scholar
  • Irene Floriani, Piero Litta, Pierfranco Conte, Simone Mocellin, Camillo Aliberti, Alessandra Casarin, Eliana Rulli, Giuseppe Lombardi, Alessandro Cappetta, Maria Ornella Nicoletto, Giovanni Randon, Sara Valpione, Alessandra Baldoni, Giulia Tasca, Zora Baretta, and Grazia Artioli, “Intraperitoneal chemotherapy in patients pretreated for ovarian cancer matched with patients treated with parenteral chemotherapy,” Anticancer Research, vol. 36, no. 12, pp. 6541–6546, 2016. View at Publisher · View at Google Scholar
  • Kennedy, Elit, Le, and Dodge, “Follow-up of patients who are clinically disease-free after primary treatment for fallopian tube, primary peritoneal, or epithelial ovarian cancer: A program in evidence-based care guideline adaptation,” Current Oncology, vol. 23, no. 5, pp. 343–350, 2016. View at Publisher · View at Google Scholar
  • Stine Lohmann, and Anna Krarup Keller, “A Case Report: Metastasis of Clear Cell Ovarian Cancer in Morrison’s Pouch as Differential Diagnosis to Exophytic Kidney Tumor,” Open Journal of Urology, vol. 06, no. 11, pp. 173–177, 2016. View at Publisher · View at Google Scholar
  • Christelle Schofield, Robert U. Newton, Daniel A. Galvão, Paul A. Cohen, and Carolyn J. Peddle-McIntyre, “A Physiological Profile of Ovarian Cancer Survivors to Inform Tailored Exercise Interventions and the Development of Exercise Oncology Guidelines,” International Journal of Gynecological Cancer, vol. 27, no. 7, pp. 1560–1567, 2017. View at Publisher · View at Google Scholar
  • Stephen C. Rubin, Paul DiSilvestro, Michael A. Bookman, Robert L. Coleman, Susanna I. Lee, Joseph Bauza, Robert S. Mannel, Joan L. Walker, Chaan S. Ng, Warner King Huh, Lainie P. Martin, John K. Chan, Ting-Yim Lee, Zheng Zhang, Helga S. Marques, Kyle Burgers, and Feng Su, “CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: An ACRIN and GOG study,” Clinical Cancer Research, vol. 23, no. 14, pp. 3684–3691, 2017. View at Publisher · View at Google Scholar
  • Bryan Oronsky, Carolyn M. Ray, Alexander I. Spira, Jane B. Trepel, Corey A. Carter, and Hope M. Cottrill, “A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer,” Medical Oncology, vol. 34, no. 6, 2017. View at Publisher · View at Google Scholar
  • Yakup Bozkaya, Mutlu Doğan, Gökmen Umut Erdem, Gökhan Tulunay, Hikmet Uncu, Zafer Arık, Umut Demirci, Ozan Yazıcı, and Nurullah Zengin, “Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer,” Journal of Obstetrics and Gynaecology, pp. 1–6, 2017. View at Publisher · View at Google Scholar
  • Sunu Lazar Cyriac, Katherine Karakasis, and Amit M. Oza, “Rucaparib for the treatment of ovarian cancer,” Expert Opinion on Orphan Drugs, pp. 1–11, 2017. View at Publisher · View at Google Scholar
  • Elizabeth Jordan, Lidia Hernandez, Michelle Ozaki, Marianne Kim, Michael J. Kruhlak, Fathi Elloumi, Carrie D. House, Margaret C. Cam, Christina M. Annunziata, Jana M. James, and Eric Batchelor, “NFkB promotes ovarian tumorigenesis via classical pathways that support proliferative cancer cells and alternative pathways that support ALDHþ cancer stem–like cells,” Cancer Research, vol. 77, no. 24, pp. 6927–6940, 2017. View at Publisher · View at Google Scholar
  • S.C. Leeson, K. Beaver, N.P.M. Ezendam, R. Mačuks, P.L. Martin-Hirsch, T. Miles, M.M. Jeppesen, P.T. Jensen, and P. Zola, “The future for follow-up of gynaecological cancer in Europe. Summary of available data and overview of ongoing trials.,” European Journal of Obstetrics & Gynecology and Reproductive Biology, 2017. View at Publisher · View at Google Scholar
  • Ahmed Ashour Ahmed, Fabrizio Miranda, Sandra Herrero-Gonzalez, Yiyan Zheng, Robert C. Bast, Charlotte Taylor, David Mannion, Mohammad Karaminejadranjbar, Karin Hellner, and Geoffrey Bartholomeusz, “Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells,” Oncotarget, vol. 8, no. 11, pp. 17960–17980, 2017. View at Publisher · View at Google Scholar
  • Sophia A. Shahin, Ruining Wang, Shirleen I. Simargi, Altagracia Contreras, Liliana Parra, Louise Qu, Wei Wen, Thanh Dellinger, Juli Unternaehrer, Fuyuhiko Tamanoi, Jeffrey I. Zink, and Carlotta A. Glackin, “Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer,” Nanomedicine: Nanotechnology, Biology and Medicine, 2018. View at Publisher · View at Google Scholar
  • Sara Westrøm, Tina B. Bønsdorff, Øyvind S. Bruland, and Roy H. Larsen, “Therapeutic Effect of α-Emitting 224 Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer,” Translational Oncology, vol. 11, no. 2, pp. 259–267, 2018. View at Publisher · View at Google Scholar
  • Christelle Schofield, Robert U. Newton, Paul A. Cohen, Daniel A. Galvão, Joanne A. McVeigh, Nicolas H. Hart, Ganendra R. Mohan, Jason Tan, Stuart G. Salfinger, Leon M. Straker, and Carolyn J. Peddle-McIntyre, “Activity Behaviors and Physiological Characteristics of Women With Advanced-Stage Ovarian Cancer,” International Journal of Gynecological Cancer, vol. 28, no. 3, pp. 604–613, 2018. View at Publisher · View at Google Scholar
  • Hanna M J L Hazenberg, Nanne K H de Boer, Chris J J Mulder, Stijn H Mom, Ad A van Bodegraven, and Greetje J Tack, MD, PhD, “Neoplasia and Precursor Lesions of the Female Genital Tract in IBD: Epidemiology, Role of Immunosuppressants, and Clinical Implications,” Inflammatory Bowel Diseases, vol. 24, no. 3, pp. 510–531, 2018. View at Publisher · View at Google Scholar